We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genetic Causes of Salivary Gland Carcinoma Discovered

By LabMedica International staff writers
Posted on 13 Feb 2019
Acinic cell carcinoma is the third most common malignant form of salivary gland cancer. More...
These tumors are similar to normal salivary gland tissue and occur most frequently in the parotid gland. Until now, the molecular causes for the illness were unknown.

Acinic cell carcinoma (AciCC) shows serous differentiation closely resembling normal acini of salivary glands, which produce major components of saliva. Regulatory rearrangements driving oncogene overexpression through enhancer hijacking or insulator dysfunction are increasingly recognized in other cancer types.

A large team of scientists led by those at the University of Erlangen-Nuremberg (Erlangen, Germany) and their colleagues enrolled 10 patients with diagnosis of AciCC of the salivary glands in the initial study cohort, and their tumor material underwent extensive comprehensive genetic and epigenetic profiling. After formalin-fixation and paraffin-embedding of tumor material, a tissue microarray was conducted with two 2 mm cores per tumor using the TMA Grandmaster automated tissue microarrayer.

Immunohistochemistry was performed on 3 µm sections freshly cut from the TMA block using a fully automated staining system, the Benchmark XT System. Representative images of tumor and normal parotid gland areas were obtained using an Axio Imager A2 microscope and AxioCam MRc at ×400 magnification. Fluorescence in situ hybridization (FISH) was performed on freshly cut sections from tumor tissue blocks. DNA from AciCC tumors and from normal salivary glands was isolated from fresh-frozen tissues using DNeasy Tissue kits, and from blood of the same patients using the DNeasy Blood Kit. Whole genome bisulfite sequencing and RNA sequencing were also performed.

The team used genome sequencing on tumor tissue, and identified a translocation of genetic material between chromosomes 4 and 9, which was present in all acinic cell carcinomas examined. Typically, such translocations in tumors lead to a new combination of genes, which then acquire new oncogenic properties. In the case of acinic cell carcinomas, the translocation that has been discovered causes regulatory elements of DNA to be transferred from an active chromosome region to a normally inactive oncogene.

When the chromosomes are rearranged, these highly active regulatory elements come into the vicinity of Nuclear Receptor Subfamily 4 Group A Member 3 (NR4A3) gene, which is usually switched off once embryonic development has been completed. The activation signals of the regulatory elements in the acinic cell carcinoma cause the gene to be switched on again. NR4A3 acts as a transcriptional factor to regulate the activity of a number of other genes, which then trigger cell division and growth, leading ultimately to the tumor starting to grow. The study was published on January 21, 2019, in the journal Nature Communications.

Related Links:
University of Erlangen-Nuremberg


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Candida Glabrata Test
ELIchrom Glabrata
New
Pan-Cancer Panel
TruSight Oncology 500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.